Oregon Public Employees Retirement Fund’s Krystal Biotech KRYS Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.23M	Buy	5,998 +49	+0.8%	+$14.6K	0.02%	531
2026 Q1	$1.54M	Buy	5,949 +53	+0.9%	+$14.1K	0.02%	639
2025 Q4	$1.45M	Buy	5,896 +57	+1%	+$12K	0.02%	654
2025 Q3	$1.03M	Buy	5,839 +37	+0.6%	+$5.54K	0.01%	832
2025 Q2	$798K	Hold	5,802	–	–	0.01%	901
2025 Q1	$1.05M	Sell	5,802 -173	-3%	-$29.1K	0.02%	739
2024 Q4	$936K	Sell	5,975 -5	-0.1%	-$887	0.02%	834
2024 Q3	$1.09M	Sell	5,980 -50	-0.8%	-$9.64K	0.02%	764
2024 Q2	$1.11M	Buy	+6,030	New	+$1.01M	0.02%	710

Other funds holding KRYS

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Oregon Public Employees Retirement Fund's KRYS Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund increased its Krystal Biotech (KRYS) stake by 0.82% in Q2 2026, buying an estimated $14.6K and bringing the position to 5,998 shares worth $2.23M. The position accounts for 0.02% of the portfolio, ranked #531.

Oregon Public Employees Retirement Fund first reported a position in KRYS in Q2 2024 and has held it in 9 quarters since. 97 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

Oregon Public Employees Retirement Fund held 5,998 shares of Krystal Biotech worth $2.23M as of Q2 2026.
Oregon Public Employees Retirement Fund bought 49 Krystal Biotech shares in Q2 2026, an estimated $14.6K.
Krystal Biotech made up 0.02% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #531 holding.
Oregon Public Employees Retirement Fund first reported a position in Krystal Biotech in Q2 2024 and has held it in 9 quarters since.
97 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.